DNA Methylation of the Glucagon-like Peptide 1 Receptor (GLP1R) in Human Pancreatic Islets

Overview

Journal BMC Med Genet

Publisher Biomed Central

Specialty Genetics

Date 2013 Jul 25

PMID 23879380

Citations 49

Authors

Elin Hall

Tasnim Dayeh

Clare L Kirkpatrick

Claes B Wollheim

Marloes Dekker Nitert

Charlotte Ling

Affiliations

Soon will be listed here.

Abstract

Background: Insulin secretion is enhanced upon the binding of Glucagon-like peptide-1 (GLP-1) to its receptor (GLP1R) in pancreatic β cells. Although a reduced expression of GLP1R in pancreatic islets from type 2 diabetic patients and hyperglycaemic rats has been established, it is still unknown if this is caused by differential DNA methylation of GLP1R in pancreatic islets of type 2 diabetic patients.

Methods: In this study, DNA methylation levels of 12 CpG sites close to the transcription start site of GLP1R were analysed in pancreatic islets from 55 non-diabetic and 10 type 2 diabetic human donors as well as in β and α cells isolated from human pancreatic islets. DNA methylation of GLP1R was related to GLP1R expression, HbA1c levels and BMI. Moreover, mRNA expression of MECP2, DNMT1, DNMT3A and DNMT3B was analysed in pancreatic islets of the non-diabetic and type 2 diabetic donors.

Results: One CpG unit, at position +199 and +205 bp from the transcription start site, showed a small increase in DNA methylation in islets from donors with type 2 diabetes compared to non-diabetic donors (0.53%, p=0.02). Furthermore, DNA methylation levels of one CpG site located 376 bp upstream of the transcription start site of GLP1R correlated negatively with GLP1R expression (rho=-0.34, p=0.008) but positively with BMI and HbA1c (rho=0.30, p=0.02 and rho=0.30, p=0.03, respectively). This specific CpG site is located in an area with known SP1 and SP3 transcription factor binding sites. Moreover, when we compared the DNA methylation of the GLP1R promoter in isolated human β and α cells, we found that it was higher in α- compared with β-cells (p=0.009). Finally, there was a trend towards decreased DNMT3A expression (p=0.056) in type 2 diabetic compared with non-diabetic islets.

Conclusions: Together, our study shows that while BMI and HbA1c are positively associated with DNA methylation levels of GLP1R, its expression is negatively associated with DNA methylation of GLP1R in human pancreatic islets.

Citing Articles

The Impact of Epigenetics on the Pathophysiology of Type 2 Diabetes and Associated Nephropathic Complications.

Mukherjee A, Debbarman T, Banerjee B, Siddiqi S Indian J Endocrinol Metab. 2025; 28(6):569-578.

PMID: 39881775 PMC: 11774419. DOI: 10.4103/ijem.ijem_43_24.

Exploring the key role of DNA methylation as an epigenetic modulator in oxidative stress related islet cell injury in patients with type 2 diabetes mellitus: a review.

Ahmed I, Chakraborty R, Faizy A, Moin S J Diabetes Metab Disord. 2024; 23(2):1699-1718.

PMID: 39610516 PMC: 11599646. DOI: 10.1007/s40200-024-01496-2.

Multi-omic human pancreatic islet endoplasmic reticulum and cytokine stress response mapping provides type 2 diabetes genetic insights.

Sokolowski E, Kursawe R, Selvam V, Bhuiyan R, Thibodeau A, Zhao C Cell Metab. 2024; 36(11):2468-2488.e7.

PMID: 39383866 PMC: 11798411. DOI: 10.1016/j.cmet.2024.09.006.

Targeting the Epigenetic Marks in Type 2 Diabetes Mellitus: Will Epigenetic Therapy Be a Valuable Adjunct to Pharmacotherapy?.

Odimegwu C, Uwaezuoke S, Chikani U, Mbanefo N, Adiele K, Nwolisa C Diabetes Metab Syndr Obes. 2024; 17:3557-3576.

PMID: 39323929 PMC: 11423826. DOI: 10.2147/DMSO.S479077.

Swimming training prevents obesity installation and normalizes hypothalamic expressions of GLP1 and leptin receptors in adult offspring born in small litters.

Fischer S, Siqueira B, Cancian C, Montes E, Vicari V, Svidnicki P Einstein (Sao Paulo). 2024; 22:eAO0619.

PMID: 39258689 PMC: 11461006. DOI: 10.31744/einstein_journal/2024AO0619.

References

Franks P, Ling C . Epigenetics and obesity: the devil is in the details. BMC Med. 2010; 8:88. PMC: 3019199. DOI: 10.1186/1741-7015-8-88. View

Parnaud G, Bosco D, Berney T, Pattou F, Kerr-Conte J, Donath M . Proliferation of sorted human and rat beta cells. Diabetologia. 2007; 51(1):91-100. DOI: 10.1007/s00125-007-0855-1. View

Xu G, Kaneto H, Laybutt D, Duvivier-Kali V, Trivedi N, Suzuma K . Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes. Diabetes. 2007; 56(6):1551-8. DOI: 10.2337/db06-1033. View

Ling C, Poulsen P, Simonsson S, Ronn T, Holmkvist J, Almgren P . Genetic and epigenetic factors are associated with expression of respiratory chain component NDUFB6 in human skeletal muscle. J Clin Invest. 2007; 117(11):3427-35. PMC: 2030455. DOI: 10.1172/JCI30938. View

Sandovici I, Smith N, Nitert M, Ackers-Johnson M, Uribe-Lewis S, Ito Y . Maternal diet and aging alter the epigenetic control of a promoter-enhancer interaction at the Hnf4a gene in rat pancreatic islets. Proc Natl Acad Sci U S A. 2011; 108(13):5449-54. PMC: 3069181. DOI: 10.1073/pnas.1019007108. View

Jiang M, Zhang Y, Liu M, Lan M, Fei J, Fan W . Hypermethylation of hepatic glucokinase and L-type pyruvate kinase promoters in high-fat diet-induced obese rats. Endocrinology. 2011; 152(4):1284-9. DOI: 10.1210/en.2010-1162. View

Doyle M, Egan J . Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol Ther. 2007; 113(3):546-93. PMC: 1934514. DOI: 10.1016/j.pharmthera.2006.11.007. View

Wei Y, Mojsov S . Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences. FEBS Lett. 1995; 358(3):219-24. DOI: 10.1016/0014-5793(94)01430-9. View

Brons C, Jacobsen S, Nilsson E, Ronn T, Jensen C, Storgaard H . Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-weight-dependent manner. J Clin Endocrinol Metab. 2010; 95(6):3048-56. DOI: 10.1210/jc.2009-2413. View

10.

Dayeh T, Olsson A, Volkov P, Almgren P, Ronn T, Ling C . Identification of CpG-SNPs associated with type 2 diabetes and differential DNA methylation in human pancreatic islets. Diabetologia. 2013; 56(5):1036-46. PMC: 3622750. DOI: 10.1007/s00125-012-2815-7. View

11.

Li L, He S, Sun J, Davie J . Gene regulation by Sp1 and Sp3. Biochem Cell Biol. 2004; 82(4):460-71. DOI: 10.1139/o04-045. View

12.

Stahle M, Brandhorst D, Korsgren O, Knutson F . Pathogen inactivation of human serum facilitates its clinical use for islet cell culture and subsequent transplantation. Cell Transplant. 2010; 20(5):775-81. DOI: 10.3727/096368910X539056. View

13.

De Marinis Y, Salehi A, Ward C, Zhang Q, Abdulkader F, Bengtsson M . GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis. Cell Metab. 2010; 11(6):543-553. PMC: 4310935. DOI: 10.1016/j.cmet.2010.04.007. View

14.

Mayo K, Miller L, Bataille D, Dalle S, Goke B, Thorens B . International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev. 2003; 55(1):167-94. DOI: 10.1124/pr.55.1.6. View

15.

Jiang M, Fei J, Lan M, Lu Z, Liu M, Fan W . Hypermethylation of hepatic Gck promoter in ageing rats contributes to diabetogenic potential. Diabetologia. 2008; 51(8):1525-33. DOI: 10.1007/s00125-008-1034-8. View

16.

Ronn T, Poulsen P, Hansson O, Holmkvist J, Almgren P, Nilsson P . Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle. Diabetologia. 2008; 51(7):1159-68. DOI: 10.1007/s00125-008-1018-8. View

17.

Holst J . The physiology of glucagon-like peptide 1. Physiol Rev. 2007; 87(4):1409-39. DOI: 10.1152/physrev.00034.2006. View

18.

Tornehave D, Kristensen P, Romer J, Knudsen L, Heller R . Expression of the GLP-1 receptor in mouse, rat, and human pancreas. J Histochem Cytochem. 2008; 56(9):841-51. PMC: 2516959. DOI: 10.1369/jhc.2008.951319. View

19.

Poirier L, Brown A, Fink L, Wise C, Randolph C, Delongchamp R . Blood S-adenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathy. Metabolism. 2001; 50(9):1014-8. DOI: 10.1053/meta.2001.25655. View

20.

Volkmar M, Dedeurwaerder S, Cunha D, Ndlovu M, Defrance M, Deplus R . DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients. EMBO J. 2012; 31(6):1405-26. PMC: 3321176. DOI: 10.1038/emboj.2011.503. View